D-PHARMA
The computed 12-month bankruptcy probability of D-PHARMA is 1.0% (low). The company has been active since 1995 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 31 yrs |
| Board | 1 |
| Locations | 1 |
| Publications | 2 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-03-2024 | micro | 28-11-2024 | 2024-00607339 |
| 31-03-2023 | micro | 30-11-2023 | 2023-00521691 |
| 31-03-2022 | micro | 30-12-2022 | 2022-20549824 |
| 31-03-2021 | micro | 29-11-2021 | 2021-78700194 |
| 31-03-2020 | micro | 13-11-2020 | 2020-70300200 |
| 31-03-2019 | micro | 02-12-2019 | 2019-75400361 |
| 31-03-2018 | micro | 30-11-2018 | 2018-73400218 |
| 31-03-2017 | micro | 30-11-2017 | 2017-70800316 |
| 31-03-2016 | volledig | 28-11-2016 | 2016-68700095 |
| 31-03-2015 | volledig | 30-11-2015 | 2015-68200067 |
-
Current01-01-2026 → present
2 events
- 01-01-2026 Appointed· Director
- 02-04-2012 Resigned· Managing director
Historic, not recently confirmed (1)
-
JEOZIF PHARMALegal entityManaging director· perm. rep.: Butros JeozifState Gazette act 13096876 (26-06-2013)Not recently confirmedlast confirmed in an act from 2013
Former directors (1)
-
Former- → 31-12-2025
| NACE primary | Retail trade(47730) |
| Legal form | Private limited company(610) |
| Incorporation | 11-07-1995 |
| Status | Active |
| Postal code | 1030 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21904B0510/00Z000 | Brussels | 686 m² | 1 · 452 m² | 25.1 m · 7 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
22-01-2026 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": true,
"effective_date": "2026-01-01",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0455.755.092",
"name_full": "D-PHARMA",
"legal_form": "SPRL"
},
"signature_regime": null,
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}26-06-2013 1 director appointed, 1 resigning
- Butros Jeozif, Gedelegeerd bestuurder
- Butros Jeozif, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Butros Jeozif",
"address": null,
"birth_date": null
},
"effective_date": "2012-04-02",
"evidence_quote": "La d\u00E9mission de son mandat de g\u00E9rant de Monsieur Butros Jeozif \u00E0 partir du 2/04/2012"
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Butros Jeozif",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0892375452",
"name": "Jeozif Pharma",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2012-04-02",
"evidence_quote": "Nom\u00EDnation de la sprl Jeozif Pharma, ayant son si\u00E8ge Av. Jan Stobbaerts 10- 1030 Bruxelles, inscrite \u00E0 la BCE sous le num\u00E9ro 0892.375.452 dont le repr\u00E9sentant permanent est Monsieur Butros Jeozif, NN 80.02 27-429.67, domicili\u00E9 Rue Emile Sergijsels 27 - 1081 Bruxelles, en tant que g\u00E9rant de la soci\u00E9t"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0455.755.092",
"name_full": "D-PHARMA",
"legal_form": "SPRL"
}
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | D-PHARMA |